Anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy

The diagnosis and management of polypoidal choroidal vasculopathy (PCV), a complex chorioretinal disease which constitutes 60% of neovascular age-related macular degeneration cases among Asians, have evolved significantly in the last decade. SD-OCT biomarkers can reliably diagnose and monitor PCV, r...

Full description

Bibliographic Details

Main Authors:	Anantharaman Giridhar, T Lekha, Kiran Chandran
Format:	Artigo
Language:	Inglês
Published:	Wolters Kluwer Medknow Publications 2026-05-01
Series:	Indian Journal of Ophthalmology
Subjects:	aflibercept anti-vascular endothelial growth factor (vegf) brolucizumab faricimab polypoidal choroidal vasculopathy pro re nata (prn) ranibizumab treat and extend (t and e)
Online Access:	https://journals.lww.com/10.4103/IJO.IJO_3237_25
Tags:	Add Tag No Tags, Be the first to tag this record!